DUSP6 and cancer: Despite the counterintuitive nature of DUSP6 overexpression in metastatic samples, given the prevailing dogma suggesting its negative regulation of the ERK/MAPK pathway, our findings were substantiated by further correlation analysis conducted with 30 PDAC cell lines from the Cancer Cell Line Encyclopedia (CCLE) and the Metastasis Map (MetMap 50034).